Thymosin Alpha 1 and Beta 4 Levels Differed in AIDS Patients vs Healthy People

Normal thymosin alpha 1 and beta 4 blood levels were established for the first time, and cord blood showed distinctive patterns suggesting thymic activity peaks at birth.

Naylor, P H et al.·International journal of immunopharmacology·1986·Preliminary EvidenceCross-Sectional
RPEP-00036Cross SectionalPreliminary Evidence1986RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Normal thymosin alpha 1 levels: 670 ± 163 pg/mL for males and 652 ± 162 pg/mL for females. Normal thymosin beta 4 levels: 974 ± 400 ng/mL for males and 889 ± 345 ng/mL for females. Note that beta 4 levels are about 1,000 times higher than alpha 1.

In AIDS patients, 57% had elevated thymosin alpha 1 and 48% had elevated thymosin beta 4. But there was no correlation between the two peptides' levels in any group, including healthy controls.

People with AIDS-related immune dysfunction (not full AIDS) showed a different pattern: 54% had elevated thymosin alpha 1 but only 15% had elevated thymosin beta 4. This suggests thymosin alpha 1 rises earlier in the disease process.

Key Numbers

How They Did This

Cross-sectional study using radioimmunoassay to measure both peptides in the same serum samples. Groups included healthy men and women, neonates (cord blood), homosexual men, and AIDS patients. The distinction between AIDS and AIDS-related immune dysfunction was made clinically.

Why This Research Matters

This was one of the first studies to establish normal reference ranges for thymosin alpha 1 and beta 4. It also showed these peptides are independently regulated and respond differently to immune crisis. The finding that thymosin alpha 1 rises first in AIDS-related immune dysfunction suggested it could serve as an early biomarker.

The Bigger Picture

Establishing normal reference ranges for thymosin peptides was essential for future clinical research. The finding that alpha 1 and beta 4 are independently regulated supports their distinct biological roles.

What This Study Doesn't Tell Us

Cross-sectional design cannot determine whether elevated thymosins cause, result from, or merely correlate with AIDS. Sample sizes for subgroups were not clearly specified. The study used 1986-era AIDS definitions, which differ from current diagnostic criteria.

Questions This Raises

  • ?Why does beta 4 circulate at 1,000× higher levels than alpha 1?
  • ?Can thymosin levels serve as diagnostic markers for immune status?

Trust & Context

Key Stat:
~1,000× concentration difference Beta 4 circulates at ng/mL levels while alpha 1 is at pg/mL
Evidence Grade:
Preliminary cross-sectional study establishing reference values — foundational but limited to radioimmunoassay methodology.
Study Age:
Published in 1986 — provided the first normal reference ranges for these peptides.
Original Title:
Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum.
Published In:
International journal of immunopharmacology, 8(7), 667-76 (1986)
Database ID:
RPEP-00036

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Why is beta 4 at so much higher levels than alpha 1?

Beta 4 has roles beyond immunity including wound healing and tissue repair. Its higher concentration reflects its broader biological functions throughout the body.

What do abnormal thymosin levels mean?

Changes from normal ranges can indicate immune dysfunction, thymic disease, or altered hormonal states. These values serve as baselines for clinical comparison.

Read More on RethinkPeptides

Cite This Study

RPEP-00036·https://rethinkpeptides.com/research/RPEP-00036

APA

Naylor, P H; Friedman-Kien, A; Hersh, E; Erdos, M; Goldstein, A L. (1986). Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum.. International journal of immunopharmacology, 8(7), 667-76.

MLA

Naylor, P H, et al. "Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum.." International journal of immunopharmacology, 1986.

RethinkPeptides

RethinkPeptides Research Database. "Thymosin alpha 1 and thymosin beta 4 in serum: comparison of..." RPEP-00036. Retrieved from https://rethinkpeptides.com/research/naylor-1986-thymosin-alpha-1-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.